Orthopedic Soft Tissue Repair Market by Procedure (Achilles Tendinosis Repair, Anterior Cruciate Ligament, Biceps Tenodesis), Injury Location (Hip, Knee, Shoulder), Product, End-User - Global Forecast 2024-2030

Orthopedic Soft Tissue Repair Market by Procedure (Achilles Tendinosis Repair, Anterior Cruciate Ligament, Biceps Tenodesis), Injury Location (Hip, Knee, Shoulder), Product, End-User - Global Forecast 2024-2030

The Orthopedic Soft Tissue Repair Market size was estimated at USD 6.19 billion in 2023 and expected to reach USD 7.08 billion in 2024, at a CAGR 15.56% to reach USD 17.04 billion by 2030.

Orthopedic soft tissue repair includes surgeries and treatments to improve joint stability by repairing the functional length of ligaments, muscles, and tendons. Soft-tissue surgeries of the lower extremity include cartilage resections or repairs, tendon transfers, muscle repairs, fasciotomies, and ligament reconstructions. The rising cases of sports-related injuries and increase in obesity rate due to changing lifestyles and food consumption patterns are resulting in an increased risk of soft tissue damage among the population. Sprains, strains, contusions, tendinitis, and bursitis are common orthopedic soft-tissue injuries. The potential suitability of additive manufacturing technology for soft tissue regeneration can aid in efficiently repairing damaged soft tissues. However, high cost and translational challenges associated with soft tissue regeneration may refrain patients from attaining orthopedic soft tissue repair surgeries and treatments. Moreover, the introduction of novel surgical techniques along with applications of orthobiologics is expected to improve the treatment outcomes for orthopedic soft tissue repair surgeries.

Regional Insights

The orthopedic soft tissue regeneration market is evolving in the Americas due to the increasing tendon and ligament injuries, growing obese population, and rising approvals for soft tissue repair treatments. Significant incidences of age-related orthopedic disorders, including damage to soft tissues, necessitate enhanced and improved soft tissue repair treatments in the APAC region. Sports and obesity-related soft tissue injuries and improving orthopedic healthcare infrastructure contribute to the expansion of the APAC's orthopedic soft tissue repair market. The EMEA region represents a highly evolving orthopedic soft tissue repair market due to the growing need for efficient treatment for accidental injuries, the increase in orthopedic soft tissue repair treatment approvals, and the rising availability of novel solutions for soft tissue repair. Additionally, ongoing research and the introduction of breakthrough technologies for treating soft tissue damage are expected to create immense potential for the growth of the orthopedic soft tissue repair market worldwide.

Market Insights

• Market Dynamics
  
  The market dynamics represent an ever-changing landscape of the Orthopedic Soft Tissue Repair Market by providing actionable insights into factors, including supply and demand levels. Accounting for these factors helps design strategies, make investments, and formulate developments to capitalize on future opportunities. In addition, these factors assist in avoiding potential pitfalls related to political, geographical, technical, social, and economic conditions, highlighting consumer behaviors and influencing manufacturing costs and purchasing decisions.
  • Market Drivers
    • Rising incidences of sports-related injuries worldwide
    • Growing aging population and obesity rate
    • Emerging utilization of 3D printing for orthopedic soft tissue regeneration
    • Market Restraints
      • High cost of orthopedic surgical procedures
      • Market Opportunities
        • Emerging innovative surgical techniques for soft tissue regeneration and orthobiologics in orthopedics
        • Rising approvals for novel soft tissue repair regenerative technologies
        • Market Challenges
          • Translational challenges in soft tissue regeneration
          • Market Segmentation Analysis
            • Procedure: suitability of epicondylitis procedures in relieving pain and restoring function in the elbow
            • End User: High dominance of hospitals setting for orthopedic soft tissue repair procedures
            • Market Disruption Analysis
            • Porter’s Five Forces Analysis
            • Value Chain & Critical Path Analysis
            • Pricing Analysis
            • Technology Analysis
            • Patent Analysis
            • Trade Analysis
            • Regulatory Framework Analysis
            FPNV Positioning Matrix
            
            The FPNV positioning matrix is essential in evaluating the market positioning of the vendors in the Orthopedic Soft Tissue Repair Market. This matrix offers a comprehensive assessment of vendors, examining critical metrics related to business strategy and product satisfaction. This in-depth assessment empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success, namely Forefront (F), Pathfinder (P), Niche (N), or Vital (V).
            
            Market Share Analysis
            
            The market share analysis is a comprehensive tool that provides an insightful and in-depth assessment of the current state of vendors in the Orthopedic Soft Tissue Repair Market. By meticulously comparing and analyzing vendor contributions, companies are offered a greater understanding of their performance and the challenges they face when competing for market share. These contributions include overall revenue, customer base, and other vital metrics. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With these illustrative details, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.
            
            Recent Developments
            • Enovis Continues Expansion of Foot & Ankle Portfolio with Knotless Syndesmotic Repair System
              
              Enovis Medical recently announced the addition of their Knotless Syndesmotic Repair System to their foot and ankle portfolio. This system is designed to enable orthopedic surgeons to perform minimally invasive syndesmotic repair procedures, which can result in a faster recovery time for patients. The Knotless Syndesmotic Repair System comprises several components, including screws, suture anchors, and buttons designed to provide robust and secure fixation while preserving soft tissue structures. Enovis Medical has been working on this technology for several years to provide improved patient outcomes through minimally invasive techniques. With the addition of this new system to its foot and ankle portfolio, Enovis Medical is set to make a significant impact in the orthopedic soft tissue repair market.
              
              Smith+Nephew unveils 'Precision in Motion' for its Orthopaedics Arthroplasty portfolio at AAOS 2023 Annual Meeting
              
              Smith+Nephew's Precision in Motion portfolio is set to revolutionize the orthopedic soft tissue repair market. This novel approach offers a comprehensive range of products with advanced technology solutions for orthopedic procedures and arthroplasty. This innovative product portfolio can reduce recovery time and improve patient outcomes by allowing for more accurate and efficient repair of soft tissues. It also features integrated digital tools that provide actionable insights into the procedure, enabling surgeons to make better decisions about techniques and treatment plans. With its comprehensive range of products and advanced technology solutions, Smith + Nephew's Precision in Motion portfolio is poised to become an industry player in orthopedic soft tissue repair.
              
              Arthrex Receives FDA Clearance for TightRope Implant as First, Only Device Cleared for Pediatric ACL Surgery
              
              The orthopedic soft tissue repair market has seen increased demand for pediatric applications, evidenced by the recent FDA clearance of Arthrex's TightRope Implant as the first and only device cleared for pediatric ACL surgery. This clearance marks a significant milestone for the company and industry as it opens up opportunities for specialized solutions for pediatric cases. It also shows that companies are investing more effort into researching and developing products that can treat specific age groups, adding to the expanding range of potential solutions. Overall, this technology enables surgeons to provide more effective treatments to their young patients while providing greater operational flexibility.
            Strategy Analysis & Recommendation
            
            The strategic analysis is essential for organizations seeking a solid foothold in the global marketplace. Companies are better positioned to make informed decisions that align with their long-term aspirations by thoroughly evaluating their current standing in the Orthopedic Soft Tissue Repair Market. This critical assessment involves a thorough analysis of the organization’s resources, capabilities, and overall performance to identify its core strengths and areas for improvement.
            
            Key Company Profiles
            
            The report delves into recent significant developments in the Orthopedic Soft Tissue Repair Market, highlighting leading vendors and their innovative profiles. These include AbbVie Inc., Acera Surgical Inc., Acumed, LLC, Amnio ReGen Solutions, Anika Therapeutics, Inc., Aroa Biosurgery Limited, Arthrex, Inc., B. Braun SE, Baxter International, Inc., Becton, Dickinson and Company, Bioventus Inc., CollPlant Biotechnologies Ltd., CoNextions Inc., CONMED Corporation, Dunamis Medical, LLC, Geistlich Pharma AG, Integra Lifesciences Holdings Corporation, Isto Biologics, Johnson & Johnson Services, Inc., Karl Storz SE & Co. KG, Maruho Medical, Inc., Medartis AG, Medtronic PLC, Mesh Suture, Inc., Novadip Biosciences S.A., Organogenesis Inc., Smith & Nephew PLC, Stryker Corporation, Teleflex Inc., Tissue Regenix Group PLC, Xiros Ltd., Zimmer Biomet Holdings, Inc., and ZimVie Inc..
            
            Market Segmentation & Coverage
            
            This research report categorizes the Orthopedic Soft Tissue Repair Market to forecast the revenues and analyze trends in each of the following sub-markets:
            • Procedure
              • Achilles Tendinosis Repair
              • Anterior Cruciate Ligament
              • Biceps Tenodesis
              • Cruciate Ligaments Repair
              • Epicondylitis
              • Gluteal Tendon Repair
              • Hip Arthroscopy
              • Rotator Cuff Repair
              • Injury Location
                • Hip
                • Knee
                • Shoulder
                • Small Joints
                • Product
                  • Fixation Devices
                    • Interference Screws
                    • Suture Anchors
                    • Transosseous Tunnels
                    • Tissue Patch
                    • End-User
                      • Ambulatory Centers
                      • Hospitals
                      • Orthopedic Clinics
                      • Region
                        • Americas
                          • Argentina
                          • Brazil
                          • Canada
                          • Mexico
                          • United States
                            • California
                            • Florida
                            • Illinois
                            • New York
                            • Ohio
                            • Pennsylvania
                            • Texas
                            • Asia-Pacific
                              • Australia
                              • China
                              • India
                              • Indonesia
                              • Japan
                              • Malaysia
                              • Philippines
                              • Singapore
                              • South Korea
                              • Taiwan
                              • Thailand
                              • Vietnam
                              • Europe, Middle East & Africa
                                • Denmark
                                • Egypt
                                • Finland
                                • France
                                • Germany
                                • Israel
                                • Italy
                                • Netherlands
                                • Nigeria
                                • Norway
                                • Poland
                                • Qatar
                                • Russia
                                • Saudi Arabia
                                • South Africa
                                • Spain
                                • Sweden
                                • Switzerland
                                • Turkey
                                • United Arab Emirates
                                • United Kingdom
                                
                                
                                Please Note: PDF & Excel + Online Access - 1 Year